Major defense stocks aren’t rising as the Iran war proceeds — they’re falling instead. Multiple defense stocks are now within striking distance of an attractive valuation.
Source: https://www.fool.com/investing/2026/04/18/3-defense-stocks-t…
Here is how Deluxe (DLX) and Exponent (EXPO) have performed compared to their sector so far this year.
Enterprise 5G use cases, surging data traffic, and major global network deals are setting the stage for ERIC, NOK, and COMM’s next growth wave.
Shares of psychedelics-related stocks climbed in early trade on Monday after US president Donald Trump signed an executive order aimed at accelerating research into psychedelic-assisted therapies and expanding patient access for certain serious mental health conditions, including post-traumatic stress disorder (PTSD) and treatment-resistant depression. The executive order, signed by Trump on Saturday, directs the US Food and Drug Administration (FDA) Commissioner to prioritize review pathways for psychedelic drugs that have received Breakthrough Therapy designation for serious mental illnesses and meet criteria under a national voucher program designed to speed regulatory review.
